Clinical Trials Logo

Chronic Total Occlusion (CTO) clinical trials

View clinical trials related to Chronic Total Occlusion (CTO).

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06322914 Completed - Clinical trials for Chronic Total Occlusion (CTO)

A Novel Scoring System for Predicting the Success of PCI in Patients With CTO

Start date: January 2012
Phase:
Study type: Observational

The investigators conducted a retrospective, single-center observational registry upon which one novel scoring system was formed and evaluated for their accuracy in predicting technical success. The investigators reviewed the clinical and angiographic records of 432 patients with 459 CTO lesions who underwent percutaneous recanalization attempts recruited between January 2012 and November 2023. The investigators aims to develop and validate a novel scoring system for predicting CTO-PCI success.

NCT ID: NCT06030271 Completed - Clinical trials for Chronic Total Occlusion (CTO)

A Prospective, Non-Randomized Pivotal Clinical Investigation to Demonstrate the Safety and Performance of the TrueCross Single-Use Microcatheter

Start date: October 13, 2022
Phase: N/A
Study type: Interventional

The trial is a pivotal clinical investigation, which is a prospective, non-randomized pivotal clinical investigation to demonstrate the safety and performance of the TrueCross Single-use Microcatheter.

NCT ID: NCT01435031 Completed - Clinical trials for Coronary Artery Disease (CAD)

EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions

EXPERT CTO
Start date: September 2011
Phase: N/A
Study type: Interventional

A prospective, multi-center, single-arm study to establish the safety and effectiveness of the XIENCE V® Everolimus Eluting Coronary Stent, XIENCE nano™ Everolimus Eluting Coronary Stent, XIENCE PRIME™ LL Everolimus Eluting Coronary Stent, HT PROGRESS and HT PILOT Coronary Guide Wires, and MINI-TREK Coronary Dilatation Catheter in patients undergoing elective percutaneous revascularization of native chronic total coronary occlusions